FDA

The FDA amended its emergency use authorizations for the Pfizer and Moderna vaccines to allow for an additional dose for some immunocompromised people.

The company said in late March that clinical trials showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents.

In a statement on Tuesday, U.S. authorities said they are "reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine."

Ohio providers are preparing to distribute more COVID-19 vaccines this week than ever.The U.S. Food and Drug Administration (FDA) authorized the COVID-19…

The Food and Drug Administration gave Johnson & Johnson's vaccine the green light for emergency use Saturday, a day after a panel of advisers to the agency endorsed it in a unanimous vote.

The Food and Drug Administration released an analysis of Johnson & Johnson's COVID-19 vaccine Wednesday morning that appears to support its authorization for emergency use.

By some measures, the Johnson & Johnson vaccine may appear to be less effective than Moderna and Pfizer. But Dr. Ashish Jha says when it comes to hospitalizations and deaths, it's just as good.

The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.

The Food and Drug Administration says is advising health workers to use "every full dose obtainable" to help speed up the nationwide immunization campaign.

The new tests produce results completely at home within 15 minutes. Experts say they could be a 'game-changer' in helping people find out quickly if they need to isolate.